Beard, Clayton W

Nonviral delivery of self-amplifying RNA vaccines

Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 675

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Brito, L. A., Chan, M., Shaw, C. A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G. R., Beard, C. W., et al. (2014) · Molecular Therapy

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 338

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice

Samsa, M. M., Dupuy, L. C., Beard, C. W., Six, C. M., Schmaljohn, C. S., Mason, P. W., Geall, A. J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy

Mosquito-borne diseases and controlRNA Interference and Gene Delivery

Cited by 63

OR25-01 Durable CYP21A2 Gene Therapy in Non-Human Primates for Treatment of Congenital Adrenal Hyperplasia

Eclov, R. J., Lewis, T. E. W., Kapadia, M., Scott, D. W., McCoy, D. D., Rouse, J. L., Romero, K. B., Beard, C. W., & Mansfield, G. S. (2020) · Journal of the Endocrine Society

Virus-based gene therapy researchSexual Differentiation and Disorders

Cited by 7

Design of a Phase 1/2 Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy in Adults With Classic Congenital Adrenal Hyperplasia (CAH) Due to 21-hydroxylase Deficiency Through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene

Merke, D. P., Auchus, R. J., Sarafoglou, K., Geffner, M. E., Kim, M. S., Escandon, R. D., Bharucha, K. N., Shaywitz, A. J., Eclov, R., Beard, C. W., et al. (2021) · Journal of the Endocrine Society

Virus-based gene therapy researchAdrenal Hormones and Disorders

Cited by 7